Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

PROGUANIL HYDROCHLORIDE CRS (10 MG)

PROGUANIL HYDROCHLORIDE CRS (10 MG)

637-32-1

DISCOVER
AMILORIDE FOR PEAK IDENTIFICATION CRS (10 MG)

AMILORIDE FOR PEAK IDENTIFICATION CRS (10 MG)

17440-83-4

DISCOVER
PHOSPHATIDYLETHANOLAMINE FROMEGG YOLK CRS (200 MG)

PHOSPHATIDYLETHANOLAMINE FROMEGG YOLK CRS (200 MG)

97281-50-0

DISCOVER
LYSOPHOSPHATIDYLCHOLINE FROM EGG YOLK CRS (200 MG)

LYSOPHOSPHATIDYLCHOLINE FROM EGG YOLK CRS (200 MG)

9008-30-4

DISCOVER
PHOSPHATIDYLCHOLINE FROM EGG YOLK CRS (250 MG)

PHOSPHATIDYLCHOLINE FROM EGG YOLK CRS (250 MG)

97281-44-2

DISCOVER
ALFUZOSIN FOR SYSTEM SUITABILITY A CRS (10 MG)

ALFUZOSIN FOR SYSTEM SUITABILITY A CRS (10 MG)

81403-68-1

DISCOVER
ISOPROPYL ISOSTEARATE CRS (5 ML)

ISOPROPYL ISOSTEARATE CRS (5 ML)

68171-33-5

DISCOVER
EVODIAMINE CRS (15 MG)

EVODIAMINE CRS (15 MG)

518-17-2

DISCOVER
PROGUANIL IMPURITY B CRS (15 MG)

PROGUANIL IMPURITY B CRS (15 MG)

106-47-8

DISCOVER
TACALCITOL MONOHYDRATE - REFERENCE SPECTRUM (N/A)

TACALCITOL MONOHYDRATE - REFERENCE SPECTRUM (N/A)

NA

DISCOVER
ERYTHROMYCIN A CRS (250 MG)

ERYTHROMYCIN A CRS (250 MG)

114-07-8

DISCOVER
HUMAN ALBUMIN (MOLECULAR SIZE) BRP (50 MG)

HUMAN ALBUMIN (MOLECULAR SIZE) BRP (50 MG)

ND

DISCOVER